Video: Diversity in Clinical TrialsImproving Research Outcomes, Targeted Drug Development

Diversity in Clinical TrialsImproving Research Outcomes, Targeted Drug Development


Dr. Coleman Obasaju

Senior Medical Director, Lilly Oncology and

Global Leader, Diversity in Clinical Research

Eli Lilly and Company

Hospitals and pharmas desperately need to get more Blacks, Latinos and Asians in their clinical trials. Learn how pharmaceutical leaders are partnering with not-for-profits to elicit specific information that will improve outcomes for these populations for diseases such as diabetes, heart disease and cancer. Get best practices in using resource groups to find and encourage more diversity in clinical trials.

To access the presentation slides, go to DiversityInc Best Practices.

Dr. Coleman Obasaju

Coleman K. Obasaju, M.D., Ph.D., is the Global Leader for Diversity in Clinical research, Global Medical Affairs Leader for Erbitux and Necitumumab and has responsibility for the US Medical Liaisons, in the Oncology Business Unit(OBU) of Eli Lilly. Dr. Obasaju received his Medical degree at the University College Hospital, Ibadan, Nigeria in 1982. He then went on to pursue post-graduate training in clinical pharmacology and medical oncology in England at the Christie Hospital and the University of Manchester, obtaining both a master’s and a doctorate degree.

Dr. Obasaju completed an Internal Medicine residency program at the University of Pennsylvania Health Systems and then went on to a combined fellowship in medical oncology/hematology in the U.S. at Fox Chase Cancer Center and Temple University Cancer Hospital, both in Philadelphia. He obtained a Clinical Investigator Training Program (CITP) Fellowship awarded by the National Cancer Institute (NCI) prior to joining Eli Lilly and Company in 2001.

Additionally, Dr. Obasaju served for four years as a member of the American Association for Cancer Research (AACR) Minority in Cancer Research Council. In that role, he provided more visibility to the scientific contribution of minority scientists and developed strategies to improve the pipeline of future minority investigators.

Click here to see more presentations from our September 2013 Healthcare Event.

Latest News

Kaiser

Kaiser Permanente Pledges $25,000 To Support Vaccine Access in Native Hawaiian Communities

Originally published at about.kaiserpermanente.org. Kaiser Permanente is a DiversityInc Hall of Fame company.   Kaiser Permanente of Hawaii has announced a $25,000 grant to Kula No Na Po‘e Hawai‘i (KULA), a Native Hawaiian beneficiary serving organization that exists to promote cultural, educational, environmental, and health equity for all. With this…

Kaiser Permanente Awards $115,000 in Grants To Support Essential Health Services for Community Organizations in Hawaii Affected by COVID-19

Originally published at about.kaiserpermanente.org. Kaiser Permanente is a DiversityInc Hall of Fame company.   Kaiser Permanente of Hawaii has awarded grants, totaling $115,000, to support two vital community organizations affected by the COVID-19 pandemic. The grants will bolster the resiliency of Lanakila Pacific and the American Red Cross of Hawaii,…

Boeing Company Expands Sustainability Alliance With Etihad Airways To Drive Innovation in the Aviation Industry

Originally published at boeing.mediaroom.com. Boeing Company ranked No. 17 on The DiversityInc Top 50 Companies for Diversity list in 2021.   On Nov. 15, Boeing and Etihad Airways announced they will expand the companies’ deep collaboration towards environmental goals. Centered on the airline’s 787 Dreamliner fleet, the new memorandum of understanding…

KPMG on Celebrating Its Military Veteran Workforce

Originally published at info.kpmg.us. KPMG ranked No. 16 on The DiversityInc Top 50 Companies for Diversity list in 2021.   As we commemorate Veterans Day and honor all who served in the United States Armed Forces, we spotlight Air Force veteran Heather Paquette and Marine Corps veteran Joe Bergeron, two KPMG professionals who are members…